Skip to Content
Merck
  • Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature.

Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature.

Reviews of infectious diseases (1986-05-01)
P G Spitzer, S M Hammer, A W Karchmer
ABSTRACT

A 55-year-old female recipient of an orthotopic liver transplant, who was receiving azathioprine, prednisone and cyclosporin, developed bacteremia due to Listeria monocytogenes. Because of a penicillin allergy, the patient was treated primarIly with trimethoprim-sulfamethoxazole, to which she responded well. The prior literature on use of trimethoprim-sulfamethoxazole in listeria infections is reviewed, and future recommendations are considered. On the basis of the experience described in this case report as well as a review of the literature, trimethoprim-sulfamethoxazole appears to be an effective treatment of listeria infections.

MATERIALS
Product Number
Brand
Product Description

Supelco
Sulfamethoxazole
Supelco
Sulfamethoxazole, VETRANAL®, analytical standard
Supelco
Sulfamethoxazole, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard
Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard